The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.
A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.
Concessions can be applied to medicines listed in Part VIIIA, Part VIIIB, and Part VIIID of the Drug Tariff. Pharmacies are automatically reimbursed at the adjusted price for that month.
The second list of price concessions for March 2025 includes:
Drug | Pack size | Price concession |
Acamprosate 333mg gastro-resistant tablets | 168 | £21.65 |
Alendronic acid 70mg tablets | 4 | £1.21 |
Amantadine 100mg capsules | 56 | £14.83 |
Codeine 15mg/5ml linctus | 200 | £16.50 |
Flucloxacillin 500mg capsules | 28 | £2.21 |
Isosorbide mononitrate 40mg tablets | 56 | £3.67 |
Methocarbamol 750mg tablets | 100 | £7.64 |
Pregabalin 100mg capsules | 84 | £2.29 |
Rizatriptan 10mg tablets | 3 | £8.10 |
Travoprost 40micrograms/ml / timolol 5mg/ml eye drops | 2.5 | £11.79 |
The initial list of price concessions for March 2025 was announced on 18 March.
Check the full list of price concessions granted for March 2025 here.
CPE has reminded contractors that price concessions only apply for the month it is granted.
“Any prices agreed for concessions requested late in the month will roll over into the following month,” it said.
NHS prescription charges remain unchanged for April 2025
CPE has also confirmed that NHS prescription charges and prescription pre-payment certificates (PPCs) will remain unchanged in April 2025, as the government has yet to finalise any increases for the 2025/26 financial year.
This means that for prescriptions dispensed in April 2025, the NHS prescription charge will remain at £9.90 per item.
Pharmacies should continue displaying their existing prescription charge notices, as there are no immediate changes, the body stated.
CPE has assured pharmacy teams that they will be updated once ministers announce any revisions, including details on implementation.
